Preimplantation Genetic Screening (PGS) Technology Market Expands...

Preimplantation Genetic Screening (PGS) Technology Market Expands with Rising Demand for Fertility and Genetic Testing

Posted 2024-11-15 07:04:31

"Preimplantation Genetic Screening (PGS) Technology Market Size And Forecast by 2031

Data Bridge Market Research analyses that the Global Preimplantation Genetic Screening (PGS) Technology Market which was USD 552.5 Million in 2021 is expected to reach USD 1228.09 Million by 2029 and is expected to undergo a CAGR of 10.50% during the forecast period of 2021 to 2029

Preimplantation Genetic Screening (PGS) Technology Market research report provides a comprehensive analysis of the market. The report aims to provide insights into Preimplantation Genetic Screening (PGS) Technology Market trends, growth opportunities, key drivers and challenges, competitive landscape, and other crucial factors that may impact the market in the forecast period (2024-2031).

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-preimplantation-genetic-screening-pgs-technology-market

Preimplantation Genetic Screening (PGS) Technology Market

Which are the top companies operating in the Preimplantation Genetic Screening (PGS) Technology Market?

The study report on the Global Preimplantation Genetic Screening (PGS) Technology Market offers a comprehensive analysis of the industry, highlighting key trends, market dynamics, and competitive landscape. It profiles prominent organizations operating in the market, examining their successful strategies and market share contributions. This Preimplantation Genetic Screening (PGS) Technology Market report provides the information of the Top 10 Companies in Preimplantation Genetic Screening (PGS) Technology Market in the market their business strategy, financial situation etc.

**Segments**

- **By Procedure Type:** The market can be segmented into preimplantation genetic diagnosis (PGD) and next-generation sequencing (NGS). PGD involves genetic testing of embryos before implantation, ensuring the selection of healthy embryos for transfer. NGS allows for comprehensive genetic screening of embryos, providing detailed information on chromosomal abnormalities and genetic disorders.

- **By Technology:** The market can be further segmented into polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP) arrays. PCR is a widely used technique for amplifying DNA segments, while FISH is used to detect chromosomal abnormalities. CGH and SNP arrays offer high-resolution analysis of genetic material, aiding in accurate screening for genetic disorders.

- **By Application:** The market segmentation based on application includes aneuploidy screening, structural rearrangements screening, single-gene disorder screening, and others. Aneuploidy screening involves the detection of abnormal chromosome numbers, while structural rearrangements screening focuses on identifying structural abnormalities in chromosomes. Single-gene disorder screening targets specific genetic mutations linked to inherited disorders.

**Market Players**

- **Thermo Fisher Scientific:** A prominent player in the global PGS technology market, Thermo Fisher Scientific offers a range of solutions for genetic analysis, including NGS platforms and PCR technologies.

- **Illumina, Inc.:** Known for its innovative sequencing technologies, Illumina provides cutting-edge NGS solutions that enable high-throughput genetic screening for applications such as PGS.

- **Agilent Technologies:** Agilent Technologies specializes in CGH arrays and other genomic solutions, catering to the demand for advanced genetic screening technologies in the PGS market.

- **PerkinElmer, Inc.:** PerkinElmer offers a diverse portfolio of genetic testing solutions, including FISH probes and sequencing instruments, supporting accurate and efficient PGS procedures.
The preimplantation genetic screening market is witnessing significant growth globally due to the increasing demand for technologically advanced genetic testing procedures to enhance the success rates of assisted reproductive techniques. The segmentation of the market based on procedure type, technology, and application provides a comprehensive overview of the diverse factors influencing market dynamics. By focusing on PGD and NGS as key procedure types, market players can target specific segments that cater to the demand for different levels of genetic screening and analysis. PGD offers a more targeted approach by screening for specific genetic disorders before embryo implantation, while NGS provides a comprehensive genomic analysis, allowing for detailed information on chromosomal abnormalities and genetic mutations.

The segmentation by technology further highlights the varied approaches available for genetic screening in the PGS market. PCR, FISH, CGH, and SNP arrays represent a range of techniques that enable precise genetic analysis and screening. PCR is a widely utilized method for DNA amplification, while FISH is effective in detecting chromosomal abnormalities. CGH and SNP arrays offer high-resolution analysis of genetic material, facilitating accurate screening for a wide range of genetic disorders. Market players can leverage these diverse technological approaches to cater to the specific needs of healthcare providers and patients seeking advanced genetic testing solutions for reproductive purposes.

Moreover, the segmentation based on application underscores the broad scope of genetic screening procedures within the PGS market. Aneuploidy screening, structural rearrangements screening, single-gene disorder screening, and other applications target specific genetic abnormalities and mutations associated with inherited disorders. By offering a range of screening applications, market players can address the diverse needs of healthcare professionals and patients seeking specialized genetic testing services for preimplantation genetic screening. These applications encompass a wide range of genetic abnormalities, providing comprehensive insights into the genetic makeup of embryos and facilitating informed decision-making during assisted reproductive procedures.

In conclusion, the preimplantation genetic screening market is characterized by a diverse range of procedures, technologies, and applications that cater to the growing demand for advanced genetic testing**Market Players:**

- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- PerkinElmer, Inc. (U.S.)
- CooperSurgical, Inc. (U.S.)
- Beijing Genomics Institute (BGI) (China)
- Abbott (U.S.)
- Siemens (Germany)
- QIAGEN (Germany)

The preimplantation genetic screening market is experiencing robust growth driven by the rising demand for advanced genetic testing techniques to improve the success rates of assisted reproduction procedures. The market segmentation based on procedure type, technology, and application offers a comprehensive insight into the factors influencing market dynamics. By focusing on preimplantation genetic diagnosis (PGD) and next-generation sequencing (NGS) as key procedure types, market players can target specific segments catering to varying needs for genetic screening and analysis. PGD allows for targeted screening of specific genetic disorders pre-implantation, while NGS provides detailed genomic analysis, offering insights into chromosomal abnormalities and genetic mutations.

The segmentation by technology showcases the diverse approaches available for genetic screening in the preimplantation genetic screening market. PCR, FISH, CGH, and SNP arrays represent a spectrum of techniques enabling precise genetic analysis. PCR is widely used for DNA amplification, FISH is effective in detecting chromosomal abnormalities, while CGH and SNP arrays offer high-resolution genetic material analysis, facilitating accurate screening

Explore Further Details about This Research Preimplantation Genetic Screening (PGS) Technology Market Report https://www.databridgemarketresearch.com/reports/global-preimplantation-genetic-screening-pgs-technology-market

Regional Analysis For Preimplantation Genetic Screening (PGS) Technology Market

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Why B2B Companies Worldwide Rely on us to Grow and Sustain Revenues:

Get a clear understanding of the Preimplantation Genetic Screening (PGS) Technology Market, how it operates, and the various stages of the value chain.
Understand the current market situation and future growth potential of the Preimplantation Genetic Screening (PGS) Technology Market throughout the forecast period.
Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market and purchase decisions of buyers.
Understand your competitors’ business structures, strategies, and prospects, and respond accordingly.
Make more informed business decisions with the help of insightful primary and secondary research sources.

This report provides Global Preimplantation Genetic Screening (PGS) Technology Market :

An in-depth overview of the global market for
Preimplantation Genetic Screening (PGS) Technology Market Assessment of the global industry trends, historical data from 2015, projections for the coming years, and anticipation of compound annual growth rates (CAGRs) by the end of the forecast period.
Discoveries of new market prospects and targeted marketing methodologies for Global Preimplantation Genetic Screening (PGS) Technology Market
Discussion of R&D, and the demand for new products launches and applications.
Wide-ranging company profiles of leading participants in the industry.
The composition of the market, in terms of dynamic molecule types and targets, underlining the major industry resources and players.
The growth in patient epidemiology and market revenue for the market globally and across the key players and Preimplantation Genetic Screening (PGS) Technology Market segments.
Study the market in terms of generic and premium product revenue.
Determine commercial opportunities in the market sales scenario by analyzing trends in authorizing and co-development deals.

Understanding market trends and industry insights at a regional level is essential for effective decision-making. Our reports are available in multiple regional languages to cater to diverse audiences. These localized reports provide in-depth analyses tailored to specific regions, ensuring businesses and stakeholders can access accurate and relevant information. By offering insights in local languages, we aim to bridge communication gaps and empower regional markets with the knowledge they need to grow and thrive. Explore our reports in your preferred language for a more personalized understanding of industry dynamics.

Data Bridge Market Research:

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 1766

Email:- corporatesales@databridgemarketresearch.com"

Preimplantation_Genetic_Screening_(PGS)_Technology_Market

Please log in to like, share and comment!